Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2023-06-29 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
2023年度以简易程序向特定对象发行股票预案
Capital/Financing Update Classification · 95% confidence The document is titled "阳普医疗科技股份有限公司 2023 年度以简易程序向特定对象发行股票预案," which translates to "Improve Medical Instruments Co., Ltd. 2023 Annual Plan for Private Placement of Shares." The content details a plan for a simplified procedure to issue shares to specific investors, including the background, purpose, issuance method, pricing, number of shares, use of proceeds, and regulatory approvals required from the Shenzhen Stock Exchange and China Securities Regulatory Commission. It discusses fundraising, capital structure optimization, and investment projects funded by the issuance. There is no indication that this is a full annual report, earnings release, or other financial report. Instead, it is a detailed announcement and plan related to capital raising through a private placement of shares. This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document length is substantial (15,000 characters), and it contains detailed substantive information about the financing plan, not just an announcement of a report or a brief notice. Therefore, the correct classification is CAP with high confidence.
2023-06-29 Chinese
独立董事关于公司第六届董事会第一次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on matters discussed at the first meeting of the sixth board of directors of Yangpu Medical Technology Co., Ltd. It includes detailed independent opinions on the appointment of senior management and the company's compliance and plans regarding a simplified procedure for issuing shares to specific targets in 2023. The content focuses on governance, compliance with laws and regulations, and approval of management and capital issuance plans. There are no financial statements or quarterly/yearly financial results presented, nor is this a transcript or a brief announcement. The document is a formal governance-related opinion by independent directors on board matters, fitting the category of Board/Management Information (MANG). The document length is 3001 characters, which is substantive and not a mere announcement or certification. Therefore, the classification is MANG with high confidence.
2023-06-29 Chinese
关于全资子公司完成医疗器械质量体系认证证书变更的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (870 characters) regarding the completion of a quality system certification change by a wholly-owned subsidiary of the company. It details the certificate update and its impact on the company but does not contain financial statements, detailed financial data, or comprehensive report content. It is an operational update related to certification, not a financial report or regulatory filing of financial results. The document is an announcement of a certification change, which fits best under Regulatory Filings (RNS) as it does not match any other specific category and is a general regulatory announcement.
2023-06-27 Chinese
关于董事会、监事会完成换届选举暨部分董事、监事离任的公告
Board/Management Information Classification · 100% confidence The document is an announcement from 阳普医疗科技股份有限公司 regarding the completion of the board of directors and supervisory board re-election, including the composition of the new board and supervisory members, as well as the departure of some directors and supervisors. It details the names, qualifications, and compliance with regulations of the new board and supervisory members, and mentions the resignation of certain individuals from their board or supervisory roles. There is no financial data, no mention of financial results, no audit information, no voting results, no dividend information, no merger or acquisition activity, and no regulatory filings or certifications. The content clearly relates to changes in the company's board of directors and senior management. Therefore, the document fits the category of Board/Management Information (MANG). The document length is 1643 characters, which is consistent with an announcement rather than a full report.
2023-06-21 Chinese
关于选举第六届监事会职工代表监事的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the election of a new employee representative supervisor to the company's sixth supervisory board. It includes details about the election process, the elected individual's background, and compliance with relevant laws and regulations. There is no financial data, no mention of financial results, no report attached or referenced, and no indication of a meeting presentation or voting results. The content is about a management/board change, specifically the election of a supervisory board member. Therefore, the document fits best under Board/Management Information (MANG). The document length is short and focused on this announcement, confirming it is not a full report or other category.
2023-06-21 Chinese
北京市中伦（广州）律师事务所对阳普医疗科技股份有限公司2023年第一次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the legality and validity of the convening, attendance, and voting procedures of the 2023 first extraordinary general meeting (EGM) of shareholders of a company. It details the election of the new board of directors and supervisory board members, the voting results, and confirms compliance with relevant laws and company articles. The document is not a report of financial results, audit, or management discussion, but a legal opinion on the shareholder meeting process and outcomes. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting results of the shareholder meeting.
2023-06-21 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.